Literature DB >> 17064811

Gefitinib in the treatment of elderly patients with advanced non-small cell lung cancer (NSCLC).

Alessandra Bearz, Lucia Fratino, Simon Spazzapan, Massimiliano Berretta, Annalisa Giacalone, Cecilia Simonelli, Umberto Tirelli.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17064811     DOI： 10.1016/j.lungcan.2006.09.017

Source DB:  PubMed          Journal:  Lung Cancer        ISSN： 0169-5002            Impact factor:   5.705


× No keyword cloud information.
  4 in total

1.  Clinical retrospective analysis of erlotinib in the treatment of elderly patients with advanced non-small cell lung cancer.

Authors:  Marco Platania; Francesco Agustoni; Barbara Formisano; Milena Vitali; Monika Ducceschi; Filippo Pietrantonio; Nicoletta Zilembo; Francesco Gelsomino; Sara Pusceddu; Roberto Buzzoni
Journal:  Target Oncol       Date:  2011-06-11       Impact factor: 4.493

Review 2.  Epidermal growth factor receptor tyrosine kinase inhibitors in elderly or poor performance status patients with advanced non-small cell lung cancer.

Authors:  Chia-Chi Lin; Chih-Hsin Yang
Journal:  Target Oncol       Date:  2009-01-20       Impact factor: 4.493

3.  Efficacy of first-line treatments in the elderly and non-elderly patients with advanced epidermal growth factor receptor mutated, non-small cell lung cancer: a network meta-analysis.

Authors:  Ziyi Xu; Chengcheng Liu; Yixiang Zhu; Zihua Zou; Tongji Xie; Puyuan Xing; Le Wang; Junling Li
Journal:  BMC Cancer       Date:  2022-05-07       Impact factor: 4.638

Review 4.  Use of geriatric assessment for older adults in the oncology setting: a systematic review.

Authors:  M T E Puts; J Hardt; J Monette; V Girre; E Springall; S M H Alibhai
Journal:  J Natl Cancer Inst       Date:  2012-07-31       Impact factor: 13.506
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.